Comprehensive Genetics and Fetal Medicine Foundation of America, Mt. Sinai School of Medicine, New York, NY, USA; Departments of Obstetrics & Gynecology, Mt. Sinai School of Medicine, New York, NY, USA.
Prenat Diagn. 2013 Oct;33(10):935-9. doi: 10.1002/pd.4167. Epub 2013 Jul 8.
Fetal reduction (FR) in multiples dramatically improves outcomes. We prioritize FR decisions for health and historically declined to factor gender. As male preferences apparently diminished, our bioethicist encouraged a re-evaluation.
Three hundred ninety-six patients reducing triplets or twins were categorized as 3➔2, 3➔1, and 2➔1, Major (M) anomaly or minor (m) anomaly, same gender (SG), and those for whom gender preference (GP) was possible. Higher order and non chorionic villus sampling were excluded. FR decisions were prioritized by M anomaly, Suspicious, or m anomaly. If neither, we considered GP.
Of 319, 214 (67%) had either M/m or SG. Of those, 3➔2 with gender option: 71/79 chose male and female or had no preferences, one chose male/male, and seven chose female/female. We reduced monochorionic twins in 33/35 3➔1 cases. Of 20 with GP choice, 10 chose male and 10 chose female. Of 162 2➔1, 54 had M or m, 50 were SG, but of the 44 M/F twins, 20 chose male and 24 chose female.
There has been a cultural shift mostly preferring one of each or having no preference. When reducing to one, >50% prefer a girl. In addition to identifying abnormalities, chorionic villus sampling before FR expands patient autonomy.
减少多胎妊娠(FR)可显著改善妊娠结局。我们优先考虑 FR 决策,以保障母婴健康,且历史上不考虑胎儿性别因素。由于男性偏好显然减少,我们的生物伦理学家鼓励重新评估。
396 名接受三胎或双胎减胎术的患者被分为 3 胎减 2 胎、3 胎减 1 胎和 2 胎减 1 胎,大(M)异常或小(m)异常,同性别(SG),以及性别偏好(GP)可能的患者。排除了多胎妊娠和非绒毛膜取样。FR 决策优先考虑 M 异常、可疑或 m 异常。如果都没有,我们会考虑 GP。
319 例患者中,214 例(67%)存在 M/m 或 SG。在这些患者中,有性别选择的 3 胎减 2 胎:71/79 选择男女或无偏好,1 例选择男男,7 例选择女女。我们减少了 33/35 例单绒毛膜双胞胎的 3 胎减 1 胎手术。20 例有 GP 选择的患者中,10 例选择男性,10 例选择女性。在 162 例 2 胎减 1 胎的患者中,54 例存在 M 或 m 异常,50 例为 SG,但在 44 例 M/F 双胞胎中,20 例选择男性,24 例选择女性。
存在文化转变,大多数人更喜欢各有一个或无偏好。当减少到一个时,超过 50%的人更喜欢女孩。除了识别异常外,绒毛膜取样可在 FR 前扩大患者的自主权。